4D Molecular Therapeutics, Inc. — Investor Relations & Filings
4D Molecular Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on inventing and developing genetic medicines to treat large-market diseases with unmet medical needs. The company utilizes its proprietary Therapeutic Vector Evolution platform, which harnesses the power of directed evolution, to create customized and optimized adeno-associated virus (AAV) vectors. These engineered vectors are designed for targeted delivery and enhanced therapeutic efficacy. 4DMT's clinical pipeline is concentrated on developing transformative products for serious conditions in ophthalmology, such as wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), and in pulmonology, including cystic fibrosis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2024-12-11 | English | |
| Director's Dealing 2024 | 2024-12-10 | English | |
| Major Shareholding Notification 2024 | 2024-12-06 | English | |
| Director's Dealing 2024 | 2024-11-25 | English | |
| SC 13G/A | 2024-11-15 | English | |
| SC 13G/A | 2024-11-14 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 12900185 | 8-K | 2024-12-11 | English | ||
| 12900187 | Director's Dealing 2024 | 2024-12-10 | English | ||
| 12900188 | Major Shareholding Notification 2024 | 2024-12-06 | English | ||
| 12900189 | Director's Dealing 2024 | 2024-11-25 | English | ||
| 12900190 | SC 13G/A | 2024-11-15 | English | ||
| 12900191 | SC 13G/A | 2024-11-14 | English | ||
| 12900192 | Major Shareholding Notification 2024 | 2024-11-14 | English | ||
| 12900193 | Major Shareholding Notification 2024 | 2024-11-14 | English | ||
| 12900194 | OWNERSHIP DOCUMENT | 2024-11-13 | English | ||
| 12900195 | 10-Q | 2024-11-13 | English | ||
| 12900196 | 8-K | 2024-11-13 | English | ||
| 12900197 | AMENDMENT NO. 3 TO SCHEDULE 13G | 2024-11-13 | English | ||
| 12900198 | Major Shareholding Notification 2024 | 2024-11-12 | English | ||
| 12900199 | Major Shareholding Notification 2024 | 2024-11-08 | English | ||
| 12900200 | Major Shareholding Notification 2024 | 2024-11-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
4D Molecular Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33060/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33060 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33060 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33060 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33060}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 4D Molecular Therapeutics, Inc. (id: 33060)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.